Discovery of a potent and selective ATAD2 inhibitor with antiproliferative activity in breast cancer models

被引：0
|
作者：
Kulkarni, Meghana M. [1 ]
Winter, Jon [2 ]
Whalley, David [3 ]
Dale, Ian [2 ]
Denz, Christopher [1 ]
Guan, Nin [1 ]
Bhavsar, Deepa [1 ]
Zhang, Andrew [1 ]
Rasmusson, Timothy [1 ]
Fretland, Adrian [1 ]
Guichard, Sylvie M. [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Waltham, England
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-A170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A170
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
    Winter-Holt, Jon J.
    Bardelle, Catherine
    Chiarparin, Elisabetta
    Dale, Ian L.
    Davey, Paul R. J.
    Davies, Nichola L.
    Denz, Christopher
    Fillery, Shaun M.
    Guerot, Carine M.
    Han, Fujin
    Hughes, Samantha J.
    Kulkarni, Meghana
    Liu, Zhaoqun
    Milbradt, Alexander
    Moss, Thomas A.
    Niu, Huijun
    Patel, Joe
    Rabow, Alfred A.
    Schimpl, Marianne
    Shi, Junjie
    Sun, Dongqing
    Yang, Dejian
    Guichard, Sylvie
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 3306 - 3331
  • [2] Potent and isoform-selective ATAD2 bromodomain inhibitor with unprecedented chemical structure and mode of action
    Fernandez-Montalvan, Amaury E.
    Berger, Markus
    Kuropka, Benno
    Koo, Seong Joo
    Badock, Volker
    Weiske, Joerg
    Holton, Simon J.
    Chaikuad, Apirat
    Diaz-Saez, Laura
    Bennett, James
    Federov, Oleg
    Huber, Kilian
    Centrella, Paolo
    Clark, Matthew A.
    Dumelin, Christoph E.
    Sigel, Eric A.
    Soutter, Holly S.
    Troast, Dawn M.
    Zhang, Ying
    Cuozzo, John W.
    Keefe, Anthony D.
    Roche, Didier
    Rodeschini, Vincent
    Huebner, Jan
    Weinmann, Hilmar
    Hartung, Ingo V.
    Gorjanacz, Matyas
    CANCER RESEARCH, 2017, 77
  • [3] Discovery of a fluorescent cyclin-dependant kinase inhibitor with potent antiproliferative activity in human breast cancer cells
    Yenugonda, Venkata Mahidhar
    Deb, Tushar B.
    Grindrod, Scott C.
    Dakshanamurthy, Sivanesan
    Yang, Yonghong
    Paige, Mikell
    Brown, Milton L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [4] ATAD2 mediates DNA replication in cancer
    Koo, Seong Joo
    Fernandez-Montalvan, Amaury Ernesto
    Holton, Simon
    von Ahsen, Oliver
    Badock, Volker
    Vittori, Sarah
    Ott, Christopher J.
    Bradner, James E.
    Gorjanacz, Matyas
    CANCER RESEARCH, 2016, 76
  • [5] Genomic alteration of bromodomain protein ATAD2 in cancer
    Takeda, Tomoyo
    Matsumura, Yuta
    Nagasaki, Hirotoshi
    Eguchi, Ken
    Takatsuka, Miki
    Shinkai, Yoichi
    Nakagawa, Hiroyuki
    Kawashima, Hitoshi
    Ueno, Hiroyuki
    Li, Chiang J.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] ATAD2 in cancer: a pharmacologically challenging but tractable target
    Hussain, Muzammal
    Zhou, Yang
    Song, Yu
    Hameed, H. M. Adnan
    Jiang, Hao
    Tu, Yaoquan
    Zhang, Jiancun
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (01) : 85 - 96
  • [7] ATAD2 is associated with malignant characteristics of pancreatic cancer cells
    Liu, Nairong
    Funasaka, Kohei
    Obayashi, Tomohiko
    Miyahara, Ryoji
    Hirooka, Yoshiki
    Goto, Hidemi
    Senga, Takeshi
    ONCOLOGY LETTERS, 2019, 17 (03) : 3489 - 3494
  • [8] Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
    Bamborough, Paul
    Chung, Chun-wa
    Furze, Rebecca C.
    Grandi, Paola
    Michon, Anne-Marie
    Sheppard, Robert J.
    Barnett, Heather
    Diallo, Hawa
    Dixon, David P.
    Douault, Clement
    Jones, Emma J.
    Karamshi, Bhumika
    Mitchell, Darren J.
    Prinjha, Rab K.
    Rau, Christina
    Watson, Robert J.
    Wemer, Thilo
    Demont, Emmanuel H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6151 - 6178
  • [9] ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
    Hou, Mingming
    Huang, Rui
    Song, Yanni
    Feng, Di
    Jiang, Yang
    Liu, Ming
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 222 - 227
  • [10] ARID1A regulation of ATAD2 in gynecologic cancer
    Shoji, Yutaka
    Conrads, Kelly A.
    Challa, Rusheeswar
    Hood, Brian L.
    Wang, Guisong
    Darcy, Kathleen M.
    Hamilton, Chad A.
    Maxwell, George Larry
    Conrads, Thomas P.
    Risinger, John I.
    CANCER RESEARCH, 2014, 74 (19)
12345